These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33832460)

  • 1. Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana.
    Amoako YA; Loglo AD; Frimpong M; Agbavor B; Abass MK; Amofa G; Ofori E; Ampadu E; Asiedu K; Stienstra Y; Wansbrough-Jones M; van der Werf T; Phillips RO
    BMC Infect Dis; 2021 Apr; 21(1):331. PubMed ID: 33832460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.
    Sarpong-Duah M; Frimpong M; Beissner M; Saar M; Laing K; Sarpong F; Loglo AD; Abass KM; Frempong M; Sarfo FS; Bretzel G; Wansbrough-Jones M; Phillips RO
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005695. PubMed ID: 28671942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.
    Tuffour J; Owusu-Mireku E; Ruf MT; Aboagye S; Kpeli G; Akuoku V; Pereko J; Paintsil A; Bonney K; Ampofo W; Pluschke G; Yeboah-Manu D
    Am J Trop Med Hyg; 2015 Aug; 93(2):216-23. PubMed ID: 26055745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: Relationship to bacterial load.
    Frimpong M; Agbavor B; Duah MS; Loglo A; Sarpong FN; Boakye-Appiah J; Abass KM; Dongyele M; Amofa G; Tuah W; Frempong M; Amoako YA; Wansbrough-Jones M; Phillips RO
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007689. PubMed ID: 31449522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions.
    Gyamfi E; Narh CA; Quaye C; Abbass A; Dzudzor B; Mosi L
    BMC Microbiol; 2021 Jan; 21(1):4. PubMed ID: 33402095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of BU-HIV co-infection.
    O'Brien DP; Ford N; Vitoria M; Christinet V; Comte E; Calmy A; Stienstra Y; Eholie S; Asiedu K
    Trop Med Int Health; 2014 Sep; 19(9):1040-7. PubMed ID: 24946829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and management of a severe paradoxical reaction associated with combined treatment of Buruli ulcer and HIV co-infection.
    Wanda F; Nkemenang P; Ehounou G; Tchaton M; Comte E; Toutous Trellu L; Masouyé I; Christinet V; O'Brien DP
    BMC Infect Dis; 2014 Jul; 14():423. PubMed ID: 25073531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing and managing wounds of Buruli ulcer patients at the primary and secondary health care levels in Ghana.
    Addison NO; Pfau S; Koka E; Aboagye SY; Kpeli G; Pluschke G; Yeboah-Manu D; Junghanss T
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005331. PubMed ID: 28245242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory confirmation of Buruli ulcer cases in Ghana, 2008-2016.
    Yeboah-Manu D; Aboagye SY; Asare P; Asante-Poku A; Ampah K; Danso E; Owusu-Mireku E; Nakobu Z; Ampadu E
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006560. PubMed ID: 29870529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.
    Klis S; Kingma RA; Tuah W; van der Werf TS; Stienstra Y
    Trop Med Int Health; 2016 Sep; 21(9):1191-6. PubMed ID: 27456068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges associated with the treatment of Buruli ulcer.
    Aboagye SY; Kpeli G; Tuffour J; Yeboah-Manu D
    J Leukoc Biol; 2019 Feb; 105(2):233-242. PubMed ID: 30168876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buruli ulcer treatment: Rate of surgical intervention differs highly between treatment centers in West Africa.
    Wadagni AC; Steinhorst J; Barogui YT; Catraye PM; Gnimavo R; Abass KM; Amofa G; Frimpong M; Sarpong FN; van der Werf TS; Phillips R; Sopoh GE; Johnson CR; Stienstra Y
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007866. PubMed ID: 31658295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buruli ulcer in Nigeria: results of a pilot case study in three rural districts.
    Ukwaja KN; Meka AO; Chukwuka A; Asiedu KB; Huber KL; Eddyani M; Chukwu JN; Anyim MC; Nwafor CC; Oshi DC; Madichie NO; Ekeke N; Njoku M; Ntana K
    Infect Dis Poverty; 2016 Apr; 5():39. PubMed ID: 27105826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with Mansonella perstans Nematodes in Buruli Ulcer Patients, Ghana.
    Phillips RO; Frimpong M; Sarfo FS; Kretschmer B; Beissner M; Debrah A; Ampem-Amoako Y; Abass KM; Thompson W; Duah MS; Abotsi J; Adjei O; Fleischer B; Bretzel G; Wansbrough-Jones M; Jacobsen M
    Emerg Infect Dis; 2014 Jun; 20(6):1000-3. PubMed ID: 24857346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports.
    Amoako YA; Frimpong M; Awuah DO; Plange-Rhule G; Boakye-Yiadom E; Agbavor B; Sarpong F; Ahor H; Adu E; Danso KG; Abass MK; Asiedu K; Wansbrough-Jones M; Phillips RO
    J Med Case Rep; 2019 Jul; 13(1):218. PubMed ID: 31315637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).
    Kibadi K; Boelaert M; Fraga AG; Kayinua M; Longatto-Filho A; Minuku JB; Mputu-Yamba JB; Muyembe-Tamfum JJ; Pedrosa J; Roux JJ; Meyers WM; Portaels F
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e736. PubMed ID: 20625556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin.
    Yeboah-Manu D; Kpeli GS; Ruf MT; Asan-Ampah K; Quenin-Fosu K; Owusu-Mireku E; Paintsil A; Lamptey I; Anku B; Kwakye-Maclean C; Newman M; Pluschke G
    PLoS Negl Trop Dis; 2013; 7(5):e2191. PubMed ID: 23658847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for Mycobacterium ulcerans infection (Buruli Ulcer) in Togo ─ a case-control study in Zio and Yoto districts of the maritime region.
    Maman I; Tchacondo T; Kere AB; Piten E; Beissner M; Kobara Y; Kossi K; Badziklou K; Wiedemann FX; Amekuse K; Bretzel G; Karou DS
    BMC Infect Dis; 2018 Jan; 18(1):48. PubMed ID: 29351741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors enhancing the control of Buruli ulcer in the Bomfa communities, Ghana.
    Agbenorku P; Agbenorku M; Amankwa A; Tuuli L; Saunderson P
    Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):459-65. PubMed ID: 21652052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic diversity of Staphylococcus aureus in Buruli ulcer.
    Amissah NA; Glasner C; Ablordey A; Tetteh CS; Kotey NK; Prah I; van der Werf TS; Rossen JW; van Dijl JM; Stienstra Y
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003421. PubMed ID: 25658641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.